沃顿科技：接受华福证券调研

Group 1 - Wharton Technology (SZ 000920) announced that on October 23, it participated in a research meeting hosted by Huafu Securities, with company representatives answering investor questions [1] - For the first half of 2025, Wharton Technology's revenue composition is as follows: Special Chemicals Manufacturing 62.64%, Plant Fiber Products Manufacturing 22.95%, Membrane Separation 9.35%, Water Reuse 3.85%, and Other Businesses 1.21% [1] - As of the report date, Wharton Technology has a market capitalization of 6.1 billion yuan [1] Group 2 - The Chinese innovative drug sector has generated $80 billion in overseas licensing deals this year, indicating a robust market for biopharmaceuticals [1] - Despite the hot secondary market for biopharmaceuticals, fundraising in the primary market is facing challenges, as discussed by Lu Gang, a partner at Chuangdong Investment [1]